(Press-News.org) May 20, 2015 -- Available research does not support the contention that athletes are uniquely at risk of chronic traumatic encephalopathy (CTE) or other neurodegenerative disorders, according to a review in the June issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Wolters Kluwer.
Widely reported and publicized cases of CTE in retired athletes overlap with other neurodegenerative disorders, while the observed symptoms could result from a wide range of other factors, suggests the review by Dr. Gavin A. Davis of Cabrini Medical Centre in Malvern, Victoria, Australia, and colleagues. They write, "[We] think there is insufficient evidence to establish a causal relationship between sports participation and the existence of modern CTE."
Experts Question Link between CTE and Sports
Over the past decade, a series of reports have described CTE as specific neurodegenerative disorder occurring in football players and other athletes. "Typically, sport-related CTE occurs in a retired athlete with or without a history of concussion(s) who presents with a constellation of cognitive, mood, and/or behavioral symptoms," according to Dr. Davis and coauthors.
Those reports have linked CTE to a history of concussions and "subconcussive impacts" during the athlete's playing career. However, because of the limitations of case series analysis, no direct causal link between concussion and CTE has been established.
Autopsy studies of athletes with CTE emphasize the presence of a protein called tau in specific areas of the brain. However, Dr. Davis and colleagues note that similar patterns of tau deposits are found in Alzheimer's disease and other common neurodegenerative disorders. These include the behavioral forms of frontotemporal dementia--the symptoms of which are "almost identical" to those of CTE.
The authors also note that a wide range of other factors can contribute to brain tau deposits, including genetic mutations, various drugs and toxins, environmental factors, and even normal aging. These factors can lead to conditions similar to CTE in people who are not athletes.
For example, tau deposits have been linked to substance abuse, including strong opiate pain medications--which are widely used by athletes. "It is likely that many of the cases with neuropathological findings represent the normal aging process, the effects of opiate abuse, or a variant of frontotemporal degeneration," Dr. Davis and coauthors write. They believe that in some cases, the clinical features may reflect depression or other mental health issues.
At a time of intense focus on the possible health effects of concussion and sports participation, Dr. Davis and coauthors hope their findings will draw attention to the limitations of the current evidence on CTE. They write, "When a previously undescribed condition, such as modern CTE in retired athletes, is proposed based on neuropathological findings in a small and potentially biased sample, then the complex genetic and environmental variables as well as the normal range of age-related brain degeneration implore us to cautiously review the data related to putative CTE."
INFORMATION:
Click here to read "Neurodegeneration and Sport."
Article: "Neurodegeneration and Sport" (doi: 10.1227/NEU.0000000000000722)
About Neurosurgery
Neurosurgery, the Official Journal of the Congress of Neurological Surgeons, is your most complete window to the contemporary field of neurosurgery. Members of the Congress and non-member subscribers receive 3,000 pages per year packed with the very latest science, technology, and medicine, not to mention full-text online access to the world's most complete, up-to-the-minute neurosurgery resource. For professionals aware of the rapid pace of developments in the field, Neurosurgery is nothing short of indispensable.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information about our products and organization, visit http://www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.
Americans' energy use continued to grow slowly in 2014, fueled by increases in the use of natural gas, wind and solar, according to the most recent energy flow charts released by Lawrence Livermore National Laboratory.
Each year, the Laboratory releases charts that illustrate the nation's consumption and use of energy. Overall, Americans used 0.9 quadrillion (quads) British thermal units (BTUs) more in 2014 than the previous year, an increase of about 1 percent.
The Laboratory also released a companion chart illustrating the nation's energy-related carbon dioxide emissions. ...
New evidence has linked Arctic warming with severe weather in countries including the UK and US.
Professor Edward Hanna and PhD student Richard Hall, from the University of Sheffield's Department of Geography, are part of a select group of international climate scientists investigating links between Arctic climate change and extreme weather in the northern mid-latitudes.
They have found that while it is too soon to know for certain whether the Arctic played a role in persistent cold events during the extreme wet UK winter of 2013/14 and recent USA East Coast winters, ...
New Haven, Conn. -- Yale researchers found a close association between acute hospitalizations and the development and progression of disability among older adults at the end of life. Their findings may have profound implications for medical decision-making for older people and those who care for them.
The research was published May 20 in The BMJ (British Medical Journal).
In an earlier study, Thomas M. Gill, M.D., professor of medicine, and his co-authors at Yale School of Medicine had shown that the course of disability for older adults at the end of life was varied ...
TAMPA, Fla. - Melanoma is predicted to result in approximately 10,000 deaths in 2015. The majority of these deaths are due to advanced stage disease that has spread or metastasized to other sites. The prognosis for patients with metastatic melanoma remains poor, with 5-year survival rates of 63 percent in patients who have metastatic disease in regional lymph nodes, and only 17 percent in patients who have metastatic disease in distant sites. Moffitt Cancer Center researchers participated in an international phase 3 study that demonstrated that a drug called ipilimumab ...
A team led by environmental engineers from Drexel University are the first independent researchers to take a closer look at the air quality effects of natural gas extraction in the Marcellus Shale region of Pennsylvania. The group used a mobile air quality monitoring vehicle to survey regional air quality and pollutant emissions at 13 sites including wells, drilling rigs, compressor stations and processing areas. Their work establishes baseline measurements for this relatively new area of extraction.
While there have been a number of studies focusing on water quality ...
The number of new Ebola cases is tapering off, but the search for new treatments continues. Now, one research team has found potential drug candidates that successfully treated up to 90 percent of mice exposed to the Ebola virus. They report their findings in the journal ACS Infectious Diseases.
Bogdan A. Solaja, Rekha G. Panchal and colleagues note that the U.S. Food and Drug Administration has yet to approve any therapeutic drugs or vaccines against the Ebola virus that, since December 2013, has infected more than 25,000 people and taken the lives of more than 10,000. ...
Despite efforts over decades to diversify the ranks of university faculty, only 4 percent of chemistry professorships at 50 leading U.S. colleges and universities are held by underrepresented minorities. That key finding and others related to diversity in academia came from a new survey conducted by a program called Open Chemistry Collaborative in Diversity Equity (OXIDE) in partnership with Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.
Senior Editor Linda Wang and Assistant Managing Editor Sophie Rovner at C&EN report that ...
HOUSTON - (May 20, 2015) - Whether people locate their sense of self in the brain or the heart can have a major influence on people's decision-making, according to a new study by management and business experts at Rice University and Columbia University.
Overall, the study found people tend to locate the self in the brain.
The paper, "Who You Are Is Where You Are: Antecedents and Consequences of Locating the Self in the Brain or the Heart," will be published in the journal Organizational Behavior and Human Decision Processes.
"We view our research as a first step ...
Twitter 'big data' could provide valuable details about transgender individuals' health and social needs
Transgender and gender nonconforming people are at high risk for diseases such as AIDS and are vulnerable to depression and other mental health issues, but may be reluctant to disclose their identities to researchers due to stigma. As a result, very little is known about their health and social needs.
New research from the UC Institute for Prediction Technology in the UCLA Department of Family Medicine suggests that social media could help fill that knowledge gap. ...
A multidisciplinary team led by Johns Hopkins researcher Venu Raman, Ph.D., with notable contributions from Guus Bol, Farhad Vesuna and Phuoc Tran of Johns Hopkins, has identified a new therapy for lung cancer, the most common cancer worldwide. The therapy has been in development for six years and involves a first-in-class molecule designed by the team. The molecule, RK-33, interrupts the cell cycle of lung cancer cells without harming normal cells, and it is effective both on its own and in combination with radiation therapy.
The team designed the molecule to bind to ...
